Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.16, Iss.1, 1995-01, pp. : 10-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological proteasome inhibitors and their therapeutic potential

By Dou Q.P. Nam S.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1263-1272

Informa Healthcare

Access to resources Recommend Favorite

A Pharmacological Primer of Biased Agonism

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 2, 2011-06 ,pp. : 92-98

Bentham Science Publishers

Access to resources Recommend Favorite

Inverse agonism: theory and practice

By Leff P.

Trends in Pharmacological Sciences, Vol. 16, Iss. 8, 1995-08 ,pp. : 256-256

Elsevier

Access to resources Recommend Favorite

Inverse agonism gains weight

By Adan R.A.H. Kas M.J.H.

Trends in Pharmacological Sciences, Vol. 24, Iss. 6, 2003-06 ,pp. : 315-321

Elsevier

Access to resources Recommend Favorite

Endogenous ligands and inverse agonism

By Baxter G.S. Tilford N.S.

Trends in Pharmacological Sciences, Vol. 16, Iss. 8, 1995-08 ,pp. : 258-259

Elsevier

Access to resources Recommend Favorite